Table of Contents
Dr Martens said business since the start of its financial year in April “has been in line with expectations”.
Dr. Martens said the operations are aimed at reducing costs.
It said business since the start of its financial year in April “has been in line with expectations” and it has remained true to its annual guidance for the year ahead – of single-digit percentage declines in sales and “a worst-case scenario” of profits falling by a third.
The boot maker has promised a detailed update on its interim results in November.
Last month, the company announced plans to make savings of £20m-£25m following a sharp fall in annual profits. Shares rose 1.6 per cent, or 1.2p, to 74.85p.
The company has been hit by supply chain problems in the US, problems that came just as an economic crisis discouraged shoppers from shelling out for its £170 shoes.
DIY INVESTMENT PLATFORMS
AJ Bell
AJ Bell
Easy investment and ready-to-use portfolios
Hargreaves Lansdown
Hargreaves Lansdown
Free investment ideas and fund trading
interactive investor
interactive investor
Flat rate investing from £4.99 per month
eToro
eToro
Stock Investing: Community of Over 30 Million
Trade 212
Trade 212
Free and commission-free stock trading per account
Affiliate links: If you purchase a product This is Money may earn a commission. These offers are chosen by our editorial team as we believe they are worth highlighting. This does not affect our editorial independence.
